Research compounds
CJC-1295 No DAC
Synthetic GHRH Analog
Sale
10 mg
For research use only. Not for human or veterinary use.
Dispatch from Vertex Labs
Same-day cutoff in
Cutoff: 3 PM ET Mon–Fri · Noon ET Sat · In-stock items
Customer experiences
Shipping, packaging & service.
Selected reviews of Vertex Labs as a store.
“Great time of delivery, came fast and safe in nice packaging very reliable would recommend”
“Discreet packaging. Well packaged. Delivered timely. I do like the price as I got a discount”
The compound
Description
CJC-1295 no DAC is a synthetic growth hormone-releasing hormone analog commonly identified as Modified GRF (1-29). Vertex Labs supplies CJC-1295 no DAC as a 10 mg lyophilized powder in a sealed research vial for controlled laboratory research, analytical evaluation, and non-clinical research workflows.
Unlike the DAC-modified variant, this research material is identified by its non-DAC peptide structure, defined sequence, and associated molecular characteristics. These properties provide clear reference points for laboratory identification, batch documentation, and controlled material tracking.
Technical profile
Product specifications
- Form
- Lyophilized Powder
- Documentation
- Batch-Level COA Available
- Compound Name
- CJC-1295 no DAC
- Alternative Names
- Modified GRF (1-29)
- Compound Class
- Synthetic GHRH Analog
All specifications
- DAC Status
- No DAC
- Peptide Length
- 29 Amino Acids
- CAS Number
- 446036-97-1
- Molecular Formula
- C152H252N44O42
- Molecular Weight
- Approx. 3367.9 g/mol
- Fill Amount
- 10 mg
- Reconstitution Status
- Not Reconstituted
- Container Type
- Sealed Vial
- Intended Use
- Laboratory Research Only
- Handling
- Qualified Personnel Only
- Storage
- Store According to Product Label
Quality & Documentation
Browse the Research Peptides & Proteins catalog to compare individual materials and labeled vial amounts.
Each CJC-1295 no DAC batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.
Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.
Handling & Storage
CJC-1295 no DAC should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the product label, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.
Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.
Research Material Identification
Batch certificates for CJC-1295 No DAC
Match the compound, presentation and lot on your vial with the original report. These records do not confirm which lot is currently shipping. A blend requires its own report; certificates for its individual components do not verify the blend.
This listing is CJC-1295 No DAC, supplied as a 10 mg individual-compound vial. Compare it with CJC-1295 with DAC 5 mg and the CJC-1295 No DAC + Ipamorelin blend, which lists 5 mg of each component. These are different research materials and require separate batch review.
Our Ipamorelin vs CJC-1295 guide explains the compound and formulation distinctions.
CJC-1295 no DAC is identified by its Modified GRF (1-29) peptide structure and absence of a Drug Affinity Complex modification. This distinction is important for differentiating the material from CJC-1295 with DAC within laboratory documentation and controlled research workflows.
Researchers should verify the vial label, fill amount, DAC status, batch number, sequence information, and corresponding analytical documentation before use. Maintaining accurate material identification and batch traceability supports consistency across individual laboratory workflows.
Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
For Research Use Only. Not for human consumption. Not for veterinary use. Not intended for diagnosis, treatment, cure, or prevention of any disease.
Batch documentation
Know your batch.
The details behind the batch
Analytical results
Results transcribed from the assigned certificate. Refer to the original report for methods and full context.
- Tested material
- CJC-1295_noDAC
- Purity
- 99.7%
- Measured content / potency
- 11.6 mg (115.7%)
- Identity
- Confirmed (FTIR)
- Report ID
- IF-824-QSA-TR006-BTL26642-01
- Appearance
- white powder
- Endotoxins
- Sterility
- Heavy metals
For research use only. A certificate describes the tested sample and is not a statement of suitability for human or veterinary use.
You may also like…
-
In StockTESA + IPA — Tesamorelin + Ipamorelin Blend
Tesamorelin · Ipamorelin5 mg + 5 mgAdd to Cart$109.00$98.10 with PEPGRADING -
-
In StockTESA (Tesamorelin)
Synthetic Peptide5 mg10 mgSee Options This product has multiple variants. The options may be chosen on the product pagePrice range: $79.00 through $119.00Price range: $71.10 through $107.10 with PEPGRADING -
In StockCJC-1295 No DAC + Ipamorelin Blend
CJC-1295 NO DAC · Ipamorelin5 mg + 5 mgAdd to Cart$99.00$89.10 with PEPGRADING -
-
Related products
Other sequences you may find relevant for your research.
-
SaleGLP-3 RT
Synthetic Peptide10 mg15 mg20 mg30 mg60 mgPrice range: $79.00 through $299.00See Options This product has multiple variants. The options may be chosen on the product page -
-
SaleVIP
Synthetic Peptide5 mgOriginal price was: $89.00.$69.00Current price is: $69.00.Add to Cart